title: Effects of coenzyme Q10 on bladder dysfunction induced by chronic bladder ischemia in a rat model.
abstract: OBJECTIVE
  We investigated the protective effects of coenzyme Q10 on bladder dysfunction in a rat model of atherosclerosis induced chronic bladder ischemia.
  
  
  METHODS
  A total of 24 male Sprague-Dawley® rats at age 16 weeks were divided into 4 groups of 6 each, including group 1--untreated, sham operated rats, group 2--coenzyme Q10 treated, sham operated rats, group 3--untreated rats with chronic bladder ischemia and group 4--coenzyme Q10 treated rats with chronic bladder ischemia. Groups 3 and 4 received an endothelial injury to the iliac arteries and were fed a 2% cholesterol diet for 8 weeks. Groups 2 and 4 were treated with coenzyme Q10 and the others were treated with vehicle for 4 weeks. Eight weeks postoperatively we performed continuous in vivo cystometry, an in vitro detrusor muscle strip study and a malondialdehyde assay. Histological examination of the bladder walls and iliac arteries was also done.
  
  
  RESULTS
  In vivo cystometry revealed that coenzyme Q10 administration after the induction of chronic bladder ischemia prolonged micturition frequency and the intercontraction interval, and increased bladder capacity compared to those in untreated rats with chronic bladder ischemia. In the detrusor muscle strip study coenzyme Q10 administration after the induction of chronic bladder ischemia increased contractile responses compared to those in untreated rats with chronic bladder ischemia. Rats with chronic bladder ischemia also showed higher malondialdehyde in bladder tissue and serum than the other groups. Chronic bladder ischemia induced submucosal fibrosis of the bladder walls and a degenerative change in the blood vessel tunical media, as shown on histological examination.
  
  
  CONCLUSIONS
  Our study suggests that coenzyme Q10 acts as an antioxidant to protect bladder function in this chronic bladder ischemia model.
authors.affiliation: Department of Urology, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Jong Wook
authors.initials: JW
authors.lastname: Kim
authors.forename: Hoon Ah
authors.initials: HA
authors.lastname: Jang
authors.forename: Jae Hyun
authors.initials: JH
authors.lastname: Bae
authors.forename: Jeong Gu
authors.initials: JG
authors.lastname: Lee
mesh_terms: D000818:Animals; D001707:Biopsy, Needle; D002908:Chronic Disease; D004195:Disease Models, Animal; D007150:Immunohistochemistry; D007511:Ischemia / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D018384:Oxidative Stress / Q000502:physiology; D020011:Protective Agents / Q000494:pharmacology*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D012680:Sensitivity and Specificity; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000494:pharmacology; D001743:Urinary Bladder / Q000098:blood supply* / Q000187:drug effects; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000473:pathology; D014563:Urodynamics / Q000187:drug effects
chemical_list: D020011:Protective Agents; D014451:Ubiquinone; D008315:Malondialdehyde; C024989:coenzyme Q10